Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Regenerative Biology

Science (IF=47.3): PIEZO1-Driven Liver Regeneration Research Supported by Cyagen Mouse Models

Cyagen Technical Content Team | July 16, 2026
Explore Cyagen's Reference Database
Discover peer-reviewed studies featuring Cyagen animal models, cell lines, and preclinical research solutions. Explore real-world applications, validated research outcomes, and supporting evidence across major therapeutic areas.
Explore Cyagen's Reference Database
Contents
01. Why this study matters 02. Building an Unassailable Evidence Chain with Cyagen Mouse Models 03. From observation to mechanism to intervention 04. What this means for regenerative medicine research 05. Cyagen perspective 06. Key takeaways 07. Reference

A Science study highlights how PIEZO1-driven mechanical signaling in Zone 2 hepatocytes converts tissue stress into spatially coordinated repair.

Liver regeneration is a profound model for understanding how adult tissues sense injury and activate repair programs. For decades, research has primarily focused on biochemical growth signals. However, mapping the precise mechanisms of how physical tissue stress translates into localized cellular repair has remained a significant translational bottleneck.

A recent landmark study published in Science (IF=47.3) elegantly overcomes this barrier. By leveraging sophisticated genetically engineered mouse models, the researchers revealed how mechanical forces dictate where and how regeneration begins. The study definitively maps how a specialized population of DPP4+ hepatocytes in Zone 2 senses post-injury tissue stiffness through the mechanosensitive ion channel PIEZO1.

1. Why this study matters

For years, Zone 2 hepatocytes have been recognized as an important source of liver renewal and regeneration. However, the field has lacked a complete explanation for why this region has a regenerative advantage over other zones of the liver lobule.

This study addresses that gap by connecting spatial identity with mechanical biology. After partial hepatectomy or chemical injury, the residual liver undergoes rapid biomechanical remodeling. Tissue stiffness, surface tension, shear stress, and cytoskeletal organization all change as the organ adjusts to a new functional load. The study shows that Zone 2 DPP4+ hepatocytes are uniquely positioned to interpret these physical cues and convert them into regenerative instructions.

This shifts the framework of liver regeneration from a purely biochemical process to a coordinated mechanobiological program. In this model, regeneration is not only triggered by soluble signals. It is also shaped by where mechanical stress is concentrated, which cells can detect that stress, and which genetic programs are activated in response.

Figure 1. Zonated mechanosensing in liver regeneration.

2. Building an Unassailable Evidence Chain with Cyagen Mouse Models

Transitioning a complex mechanobiological hypothesis into a Science-caliber publication requires an airtight in vivo strategy. To visualize cell fate and validate whether enhanced PIEZO1 activity could fundamentally improve regeneration, the research team utilized highly precise Rosa26-mTmG and Piezo1-GOF mouse models, expertly generated by Cyagen.

Rosa26-mTmG for Lineage Tracing and Cell-Fate Mapping: When crossed with appropriate Cre or Dre driver lines, this robust reporter system empowered researchers to accurately trace how specific cell populations expand, migrate, and drive tissue reconstruction overtime.

Piezo1-GOF for Functional Validation: Moving beyond mere observation, this gain-of-function model allowed the team to strengthen PIEZO1 signaling in defined biological contexts. Crucially, the model demonstrated that hepatocyte-specific activation of PIEZO1 actively enhanced regenerative capacity following partial hepatectomy and carbon tetrachloride injury. This provided the definitive in vivo proof that PIEZO1 is a functional driver of repair, not just a passive marker.

Figure 2. PIEZO1 mutation enhances liver regeneration capacity.

3. From observation to mechanism to intervention

One of the most compelling aspects of the study is its stepwise logic.

First, DPP4 was identified as a marker of a proliferative Zone 2 hepatocyte population. Next, lineage-tracing experiments demonstrated that DPP4+ hepatocytes contribute to homeostatic renewal and expand after injury, with their progeny helping repopulate the liver lobule. The researchers then characterized the mechanical microenvironment after injury and found that Zone 2 becomes a hotspot of increased stiffness, tension, and viscoelastic remodeling.

Figure 3. DPP4+ hepatocytes drive whole-liver repair.

Mechanistically, PIEZO1 expression was enriched in DPP4+ Zone 2 hepatocytes, giving these cells a specialized ability to detect mechanical stress. PIEZO1 activation promoted calcium signaling, which engaged NFATC3 and induced IGFBP2 expression. Functional rescue experiments further showed that IGFBP2 can reverse regenerative defects caused by Piezo1 loss, placing IGFBP2 as a key downstream effector of this pathway.

Together, these findings define a mechanosensing-to-proliferation axis: PIEZO1 -> NFATC3 -> IGFBP2. This pathway explains how local tissue mechanics can be translated into spatially precise regenerative growth.

4. What this means for regenerative medicine research

The implications extend beyond liver biology. Many regenerative and degenerative disease settings involve changes in tissue mechanics, including fibrosis, cardiac remodeling, skeletal muscle injury, wound repair, and chronic inflammatory damage. Models that allow researchers to trace specific cell populations, manipulate mechanosensitive pathways, and test injury responses in vivo can help reveal whether similar logic applies across organs.

For preclinical research teams and academic labs, this study exemplifies how advanced Cyagen mouse models can accelerate high-impact discoveries across multiple disease states:

  • Mapping Cellular Origins: Precisely trace the origin and fate of regenerative cell populations in vivo.
  • Validating Disease Drivers: Confirm tissue-specific mechanisms of repair or pathological fibrosis.
  • Testing Target Efficacy: Execute rigorous loss-of-function and gain-of-function mechanism testing within intact physiological systems.
  • Bridging Omics and Function: Connect single-cell or spatial transcriptomics data directly to functional biology.

The broader lesson is that publication-ready regenerative biology increasingly depends on integrated model strategies. A single assay rarely answers the full question. High-impact studies often require the ability to identify the right cell population, manipulate the right gene in the right context, and validate the effect across multiple biological layers.

5. Cyagen perspective

At Cyagen, we see genetically engineered mouse models as more than experimental tools. They are platforms for turning biological hypotheses into rigorous, interpretable, and publishable in vivo evidence.

From reporter and lineage-tracing models to conditional knockout, knock-in, gain-of-function, humanized, and disease-relevant models, well-designed mouse systems can help researchers move from correlation to causation. In complex fields such as organ regeneration, mechanobiology, metabolic disease, fibrosis, oncology, immunology, neuroscience, and cardiovascular research, this distinction is often what separates a descriptive finding from a mechanistic discovery.

By providing reliable model design, generation, validation, and supporting services, Cyagen helps researchers build the type of coherent in vivo evidence chain that can support stronger manuscripts and more impactful translational conclusions.

Explore more Cyagen-supported citation articles: https://www.cyagen.com/reference/model-citations

Search Our Repository of 38,000+ Ready-to-Use Mouse Models: https://www.cyagen.com/mouseatlas

Consult with Our Experts to Design Your Next High-Impact In Vivo Study: https://www.cyagen.com/about-us/contact

6. Key takeaways

  • Zone 2 DPP4+ hepatocytes act as a specialized regenerative cell population in the liver.
  • PIEZO1 enables these cells to sense post-injury mechanical changes in stiffness and tension.
  • The PIEZO1 -> NFATC3 -> IGFBP2 axis converts mechanical signals into proliferative instructions.
  • Gain-of-function activation of PIEZO1 enhances liver regeneration in injury models.
  • Advanced mouse models, including reporter and gain-of-function systems, are essential for connecting cell identity, mechanism, and therapeutic potential.

7. Reference

[1] Zhang Y, Sun Y, Xu G, et al. Zonated mechanosensing by PIEZO1 controls liver regeneration. Science. 2026 Jul 2;393(6806):eaef0825.

Subscribe to Receive Updates & Promotions From Cyagen
Subscribe
* Your privacy matters to us. We never share it with third parties.
Explore More
Science (IF=47.3): PIEZO1-Driven Liver Regeneration Research Supported by Cyagen Mouse Models
Accelerating Alzheimer's Research Using Advanced iPSC Platforms
MND Awareness Day 2026: Overcoming ALS Drug Development Bottlenecks with Predictive In Vivo Tools
The PROTAC Era: From VEPPANU’s Landmark Approval to the Next Generation of CRBN-Targeted Therapies
Share
Top
Ready to Elevate Your Research?
Discover how Cyagen can support your research. Let’s start a conversation.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research